Industry’s first dedicated Neuromuscular Drug Development (NMD) Summit

Neuromuscular diseases are a huge unmet clinical need, with huge advances and excitement in the field now is the time combine forces and help accelerate development of truly curative neuromuscular therapeutics.

The inaugural Neuromuscular Drug Development Summit is industry’s first dedicated discussion and networking forum focused on bringing together neuromuscular thought-leaders to share the latest scientific progress and address the current challenges drug developers are facing. With the mission to enable drug developers to solve the challenges in bringing truly transformative therapeutics to market.

Join 60 of your peers and be part of this unique opportunity to engage in cross-industry discussions and presentations from over 22 expert speakers on latest developments, sharing insights and science to elevate clinically effective neuromuscular therapeutic pipelines.

Download the full event guide here to view the complete agenda and companies speaking.

Developed in combination with experts from Sarepta, Novartis, Sanofi and other leading organisations, this industry-focused forum allows you to explore overcoming limited patient populations, innovations within gene therapy and the use of biomarkers and endpoints for increased efficacy in clinical trials to name a few.

Leave NMD with a deeper understanding of the clinical, preclinical and regulatory landscape surrounding neuromuscular drug development.